The Journal of Clinical Endocrinology & Metabolism · 2007 · 112 citations · 37 references
MedicineEndocrinologyPediatricsInfertilityPediatric EndocrinologyReproductive EndocrinologyAdrenal TumorsMale InfertilityMale Reproductive EndocrinologyTesticular DisordersTesticular FunctionTesticular UltrasonographyAnti-müllerian Hormone TestingBiomarkers Of Testicular FunctionLeydig Cell TumorsPediatric Testicular TumorsSertoli Cell EndocrinologySertoli Cell TumorsTesticular Adrenal Rest TumorsTesticular Function Assessment
CONTEXT: Infertility observed in adult males with congenital adrenal hyperplasia (CAH) has been associated with testicular adrenal rest tumors (TART) that may originate during childhood. OBJECTIVE: Our objective was to describe the prevalence of TART and Sertoli and Leydig cell function in a group of boys aged 2-10 yr with CAH and to compare prevalence with that of a control group. DESIGN: From August 2005 to January 2007, 19 patients with classical CAH (CAH group) were referred from seven endocrinology centers. METHODS: We studied 19 subjects in the CAH group and, as a control group, 13 boys from the community that did not have testicular diseases. A complete physical exam was performed. High-resolution ultrasound was used to determine TART prevalence. Inhibin B and anti-Müllerian hormone were used as Sertoli cell markers. The ratio between basal testosterone levels and testosterone levels 72 h after beta-human chorionic gonadotropin (5000 U/m2) treatment [(T72- T0)/T0] was used to evaluate Leydig cell response. RESULTS: CAH and control groups were comparable in chronological age (5.9 vs. 5.6 yr; P = 0.67) and bone age/chronological age ratio (1.09 vs. 1.03; P = 0.09). TART prevalence was four of 19 (21%) in the CAH group. Lower values for inhibin B (49.2. vs. 65.2 pg/ml; P = 0.018), anti-Müllerian hormone (70.1 vs. 94.2 ng/ml; P = 0.002), and (T72- T0)/T0 (5.6 vs. 13.6; P < 0.01) were observed in the CAH group. CONCLUSION: TART in prepubertal males with classic CAH could be found during childhood. We also report differences in markers of gonadal function in a subgroup of patients, especially in those with inadequate control.
37
CDC growth charts: United States.
Robert J. Kuczmarski, Cynthia L. Ogden, Laurence M. Grummer‐Strawn et al. · PubMed · 2000 · 5.2K citations
Tina Kold Jensen, Anna‐Maria Andersson, Niels Henrik Hjøllund et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 300 citations · Full text
Nike Stikkelbroeck, Barto J. Otten, Arifa Pasic et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 297 citations
Medicine, Endocrinology, Andrology +12